SEC Form 4 · accession 0001610717-26-000294
Arcus Biosciences, Inc. · RCUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Juan C. Jaen
Officer — President
Period of report
Jun 22, 2026
Accepted (ET)
Jun 24, 2026 · 5:41 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001724521
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 22, 2026 | S | 9,236 | $27.0313 | D | 913,004 | I | By Trust |
| Common StockF3 | Jun 23, 2026 | S | 14,067 | $27.6875 | D | 898,937 | I | By Trust |
| Common StockF4 | Jun 23, 2026 | S | 1,697 | $28.0612 | D | 897,240 | I | By Trust |
| Common StockF5 | Jun 24, 2026 | S | 6,431 | $29.6595 | D | 890,809 | I | By Trust |
| Common StockF6,F7 | holding | — | — | — | 378,291 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026.
- F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F3The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.01 to $28.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F4The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.0050 to $28.1550, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F5The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.50 to $29.8050, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F6Includes the unvested portion of the Reporting Person's RSU grants.
- F7Includes 1,279 shares purchased on May 31, 2026 through the Company's Employee Stock Purchase Plan.